Inventor
GRIFFITH HUGH
GB19 patents
Patents
19 patentsUS10117888B2Nov 6, 2018
Formulation comprising a gemcitabine-prodrug
NuCana plc23 citations92
US11040051B2Jun 22, 2021
Formulation comprising a gemcitabine-prodrug
NuCana plc4 citations82
US10786523B2Sep 29, 2020
Formulation comprising a gemcitabine-prodrug
NuCana plc8 citations82
US10570168B2Feb 25, 2020
2′ and/or 5′ amino-acid ester phosphoramidate 3′-deoxy adenosine derivatives as anti- cancer compounds
NuCana plc5 citations80
US10669300B2Jun 2, 2020
Methods of separating gemcitabine-phosphate diastereoisomers
NuCana plc2 citations72
US10660912B2May 26, 2020
Combination therapy for cancer
NuCana plc4 citations72
US10906929B2Feb 2, 2021
Phosphoramidate nucleoside derivatives as anticancer agents
NuCana plc2 citations71
US10662213B2May 26, 2020
Gemcitabine prodrugs
NuCana plc3 citations71
US11352387B2Jun 7, 2022
2′ and/or 5′ amino-acid ester phosphoramidate 3′-deoxy adenosine derivatives as anti-cancer compounds
NuCana plc2 citations69
US11377467B2Jul 5, 2022
Crystalline form of gemcitabine
NuCana plc0 citations61
US12357652B2Jul 15, 2025
Formulations of phosphoramidate derivatives of nucleoside drugs
NuCana plc0 citations60
US12054511B2Aug 6, 2024
Synthesis of phosphate derivatives
NuCana plc0 citations60
US11786544B2Oct 17, 2023
Formulations of phosphoramidate derivatives of nucleoside drugs
NuCana plc0 citations60
US11707477B2Jul 25, 2023
Formulation comprising a gemcitabine-prodrug
NuCana plc0 citations60
US11629164B2Apr 18, 2023
Gemcitabine prodrugs
NuCana plc0 citations60
US11414452B2Aug 16, 2022
Synthesis of phosphate derivatives
NuCana plc1 citations60
US12054510B2Aug 6, 2024
2′ and/or 5′ amino-acid ester phosphoramidate 3′-deoxy adenosine derivatives as anti-cancer compounds
NuCana plc0 citations57
US11400107B2Aug 2, 2022
Cancer treatments
NuCana plc1 citations57
US11560400B2Jan 24, 2023
Salts of diphosphate phosphoramidate of nucleosides as anticancer compounds
NuCana plc0 citations49